Serial Number | 79081065 |
Word Mark | ECTYCELL |
Filing Date | Friday, October 2, 2009 |
Status | 404 - IR CANCELLED - US REGISTRATION CANCELLED |
Status Date | Thursday, October 3, 2019 |
Registration Number | 3939980 |
Registration Date | Tuesday, April 5, 2011 |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, January 18, 2011 |
Goods and Services | Chemical, biochemical, biotechnological and bacteriological products for use in industry, science, agriculture, horticulture, namely, chemicals used for industrial purposes, polypeptides for in vivo and in vitro genetic engineering, nucleic acid vectors, natural and engineered meganucleases and endonucleases; chemical, biochemical, biotechnological and bacteriological products for use in research and testing laboratories, namely, polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors; chemical, biochemical, biotechnological and bacteriological preparations for scientific purposes namely, bacteriological preparations producing polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors; diagnostic preparations for scientific purposes; proteins being raw materials |
Goods and Services | Pharmaceutical, veterinary and sanitary products, namely, foods, dietetic beverages, and beverages for medical purposes, nutritional supplements for medical use, cultures and preparations of microorganisms for medical, pharmaceutical and veterinary purposes, bacteriological preparations for medical, pharmaceutical and veterinary purposes, medicines for veterinary purposes derived from or validated with stem-cell derived biologicals and for treating genetic diseases including proliferative disorders such as cancer, immunomodulatory disorders such as immunodeficiency and autoimmune syndromes, single gene disorders such as autosomal dominant, autosomal recessive, X-linked dominant, X-linked recessive, Y-linked and Mitochondrial linked diseases, multifactorial and polygenic disorders, infectious diseases including those caused by pathogenic microbial agents, including pathogenic viruses, pathogenic bacteria, fungi, protozoa, multicellular parasites, medicines for human purposes derived from or validated with stem-cell derived biologicals and for treating genetic diseases including proliferative disorders such as cancer, immunomodulatory disorders such as immunodeficiency and autoimmune syndromes, single gene disorders such as autosomal dominant, autosomal recessive, X-linked dominant, X-linked recessive, Y-linked and Mitochondrial linked diseases, multifactorial and polygenic disorders, infectious diseases including those caused by pathogenic microbial agents, including pathogenic viruses, pathogenic bacteria, fungi, protozoa, multicellular parasites, biological preparations for medical, pharmaceutical and veterinary purposes for grafts, cell therapy and regenerative medicine, for treating genetic diseases including proliferative disorders such as cancer, immunomodulatory disorders such as immunodeficiency and autoimmune syndromes, single gene disorders such as autosomal dominant, autosomal recessive, X-linked dominant, X-linked recessive, Y-linked and Mitochondrial linked diseases, multifactorial and polygenic disorders, infectious diseases including those caused by pathogenic microbial agents, including pathogenic viruses, pathogenic bacteria, fungi, protozoa, multicellular parasites, chemical and biochemical preparations for medical, pharmaceutical and veterinary purposes for treating genetic diseases including proliferative disorders such as cancer, immunomodulatory disorders such as immunodeficiency and autoimmune syndromes, single gene disorders such as autosomal dominant, autosomal recessive, X-linked dominant, X-linked recessive, Y-linked and Mitochondrial linked diseases, multifactorial and polygenic disorders, infectious diseases including those caused by pathogenic microbial agents, including pathogenic viruses, pathogenic bacteria, fungi, protozoa, multicellular parasites, chemical-pharmaceutical preparations for treating genetic diseases including proliferative disorders such as cancer, immunomodulatory disorders such as immunodeficiency and autoimmune syndromes, single gene disorders such as autosomal dominant, autosomal recessive, X-linked dominant, X-linked recessive, Y-linked and Mitochondrial linked diseases, multifactorial and polygenic disorders, infectious diseases including those caused by pathogenic microbial agents, including pathogenic viruses, pathogenic bacteria, fungi, protozoa, multicellular parasites, diagnostic preparations for medical purposes |
Goods and Services | Scientific apparatus and instruments used in the implementation of biochemical analysis and molecular biology techniques, namely, automated biochemical analyzer, automated protein production and protein purification devices, biochemical, biological automated assay devices, nucleic acid break analyzer, devices for protein-nucleic acid interaction analysis; scientific apparatus and instruments for the mapping of all molecules' biological activities; data processing apparatus; multimedia products, namely, blank magnetic, blank optical, blank image and blank sound recording media; software for recording scientific and medical data on an on-line computer database in the field of pharmaceuticals and biotechnology, for simulation and design of biological and chemical products; apparatus and instruments for non-medical diagnosis, namely, computer hardware, microscopes, spectrometers |
Goods and Services | Scientific research and industrial research in the field of genome engineering, protein engineering; scientific research in the field of genetics, medical, pharmaceutical and veterinary research; scientific research in the field of biology, biochemistry, molecular biology, bacteriology; scientific analysis; scientific research and development of biochemical, biological and molecular biology analysis techniques; research and development of new molecules for industrial use, scientific laboratory services, namely, isolation and preparation of stem cells; laboratory services, namely, imaging core lab services; engineering services, particularly technical project planning; computer programming, computer software and multimedia software design and development |
Goods and Services | Intellectual property licensing; patent licensing |
International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
US Class Codes | 001, 005, 006, 010, 026, 046 |
Class Status Code | F - NOT AVAILABLE |
Class Status Date | Friday, November 10, 2017 |
Primary Code | 001 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | F - NOT AVAILABLE |
Class Status Date | Friday, November 10, 2017 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
US Class Codes | 021, 023, 026, 036, 038 |
Class Status Code | F - NOT AVAILABLE |
Class Status Date | Friday, November 10, 2017 |
Primary Code | 009 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | F - NOT AVAILABLE |
Class Status Date | Friday, November 10, 2017 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
US Class Codes | 100, 101 |
Class Status Code | F - NOT AVAILABLE |
Class Status Date | Friday, November 10, 2017 |
Primary Code | 045 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | CELLECTIS |
Party Type | 30 - Original Registrant |
Legal Entity Type | 99 - Other |
Address | FR |
Party Name | CELLECTIS |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 99 - Other |
Address | FR |
Party Name | CELLECTIS |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | FR |
Event Date | Event Description |
Friday, April 17, 2020 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED |
Friday, April 17, 2020 | DEATH OF INTERNATIONAL REGISTRATION |
Thursday, May 2, 2019 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
Friday, September 14, 2018 | TOTAL INVALIDATION PROCESSED BY THE IB |
Thursday, July 19, 2018 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
Thursday, July 19, 2018 | INVALIDATION PROCESSED |
Tuesday, July 10, 2018 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
Friday, November 10, 2017 | CANCELLED SECTION 71 |
Thursday, March 27, 2014 | NEW REPRESENTATIVE AT IB RECEIVED |
Sunday, May 19, 2013 | FINAL DECISION TRANSACTION PROCESSED BY IB |
Thursday, February 28, 2013 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Monday, August 29, 2011 | FINAL DISPOSITION NOTICE SENT TO IB |
Monday, August 29, 2011 | FINAL DISPOSITION PROCESSED |
Tuesday, July 5, 2011 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
Tuesday, April 5, 2011 | REGISTERED-PRINCIPAL REGISTER |
Tuesday, January 18, 2011 | PUBLISHED FOR OPPOSITION |
Wednesday, December 29, 2010 | NOTICE OF PUBLICATION |
Monday, December 13, 2010 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
Monday, December 13, 2010 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Friday, November 19, 2010 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, November 19, 2010 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, November 19, 2010 | ASSIGNED TO LIE |
Thursday, November 4, 2010 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Friday, June 18, 2010 | REFUSAL PROCESSED BY IB |
Friday, May 7, 2010 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Friday, May 7, 2010 | REFUSAL PROCESSED BY MPU |
Wednesday, May 5, 2010 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Tuesday, May 4, 2010 | NON-FINAL ACTION WRITTEN |
Tuesday, April 27, 2010 | APPLICATION FILING RECEIPT MAILED |
Friday, April 23, 2010 | ASSIGNED TO EXAMINER |
Friday, April 23, 2010 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
Thursday, April 22, 2010 | SN ASSIGNED FOR SECT 66A APPL FROM IB |